Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Arsenic Trioxide × Clear all

NCT00053222 2013-09-05

Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms